Home » Stocks » USRM

U.S. Stem Cell, Inc. (USRM)

Stock Price: $0.0100 USD 0.0000 (0.00%)
Updated Jul 26, 2021 10:14 AM EDT - Market open
Market Cap 4.48M
Revenue (ttm) 303,975
Net Income (ttm) -3.29M
Shares Out 444.84M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 26
Last Price $0.0100
Previous Close $0.0100
Change ($) 0.0000
Change (%) 0.00%
Day's Open 0.0100
Day's Range 0.0093 - 0.0100
Day's Volume 549,002
52-Week Range 0.0033 - 0.0870

News

There are no news available yet.

About USRM

U.S. Stem Cell, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of autologous cellular therapies for the treatment of chronic and acute heart damage, and vascular and autoimmune diseases in the United States. Its lead product candidates include MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells or cells from a patient's body for enhancing cardiac function in chronic heart failure patients; and AdipoCell, a patient-derived cell ... [Read more...]

Industry
Biotechnology
IPO Date
Feb 15, 2008
CEO
Mike Tomas
Country
United States
Stock Exchange
OTCMKTS
Ticker Symbol
USRM
Full Company Profile

Financial Performance

In 2020, U.S. Stem Cell's revenue was $277,087, a decrease of -90.98% compared to the previous year's $3.07 million. Losses were -$2.89 million, -24.64% less than in 2019.

Financial Statements